Cefotaz S 500mg/250mg Injection
Marketer
V Care Biotech
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefotaz S 500mg/250mg Injection
Cefotaz S 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional; strict adherence to the prescribed regimen is crucial, even with symptom improvement, to ensure efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate prompt medical help. Prior to use, disclose all medications and pre-existing conditions to your physician. Pregnant or lactating individuals require medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occurs. Ample rest, nutritious food, and hydration are recommended for optimal recovery. Monitoring through laboratory tests may be employed to assess treatment response.
Uses of Cefotaz S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefotaz S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefotaz S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefotaz S 500mg/250mg Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
How Cefotaz S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefotaz S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Cefotaz S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefotaz S (500mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, research involving human subjects is currently insufficient.
Breast feedingCAUTION
Administering Cefotaz S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Cefotazime 500mg/250mg injection may induce drowsiness, blurred vision, or dizziness. Driving is inadvisable if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefotaz S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Cefotaz S 500mg/250mg Injection cautiously, with potential dose modification. Mild to moderate liver dysfunction does not typically necessitate dose alteration of Cefotaz S 500mg/250mg Injection. Physician consultation is advised.
What if you forget to take Cefotaz S 500mg/250mg Injection :
Omit a Cefotaz S 500mg/250mg Injection dose? Seek medical advice.
Facts to Know About Cefotaz S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently